Objective: The quality of life(QoL) of patients with chronic diseases is a greater concern for both patients and clinicians. This study was aimed to develop and evaluate the second version of the General Module of Quality of Life Instruments for Chronic Diseases (QLICD-GM(V2.0)) by Classical Test Theory (CTT) and Item Response Theory (IRT) .
Methods: Building upon QLICD-GM(V1.0), the scale was developed and validated through a structured process combining qualitative and quantitative methods. The psychometric properties of QLICD-GM(V2.0) were assessed in a sample of 1953 patients with ten chronic diseases, evaluating reliability, validity, responsiveness, and item characteristics under CTT and IRT frameworks.
Results: The final QLICD-GM(V2.0) comprises 28 items across 3 domains and 9 facets. Item-domain correlations were highest for each item within its intended domain, except one. Confirmatory factor analysis indicated good model fit. Criterion validity against SF-36 showed correlations of 0.56 (physical), 0.54 (psychological), and 0.46 (social). Internal consistency was high (Cronbach's α: 0.79-0.98). Significant pre- to post-treatment score differences were found (all p < 0.001), with standardized response means of 0.24 (physical), 0.17 (psychological), and 0.07 (social). IRT analysis indicated all items had discrimination parameters between 1.11 and 1.41, with monotonically increasing location parameters. Average item information amount was approximately 0.33 (physical), 0.54 (psychological), and 0.44(social).
Conclusions: QLICD-GM(V2.0) provides a psychometrically sound, clinically interpretable and responsive measure of generic QoL in chronic patients. It can be used alone or combined with disease-specific modules to monitor benefit and guide treatment and rehabilitation planning.
{"title":"Development and validation of the general module of the quality of life instruments for chronic diseases QLICD-GM(V2.0) : a large sample study based on classical test theory and item response theory.","authors":"Chonghua Wan, Xiaoqing Zhang, Liyuan Qiao, Wu Li, Ying Chen, Wanrui Ma, Honghong Xue, Peng Quan, Dandan Wang","doi":"10.1186/s12955-026-02493-0","DOIUrl":"https://doi.org/10.1186/s12955-026-02493-0","url":null,"abstract":"<p><strong>Objective: </strong>The quality of life(QoL) of patients with chronic diseases is a greater concern for both patients and clinicians. This study was aimed to develop and evaluate the second version of the General Module of Quality of Life Instruments for Chronic Diseases (QLICD-GM(V2.0)) by Classical Test Theory (CTT) and Item Response Theory (IRT) .</p><p><strong>Methods: </strong>Building upon QLICD-GM(V1.0), the scale was developed and validated through a structured process combining qualitative and quantitative methods. The psychometric properties of QLICD-GM(V2.0) were assessed in a sample of 1953 patients with ten chronic diseases, evaluating reliability, validity, responsiveness, and item characteristics under CTT and IRT frameworks.</p><p><strong>Results: </strong>The final QLICD-GM(V2.0) comprises 28 items across 3 domains and 9 facets. Item-domain correlations were highest for each item within its intended domain, except one. Confirmatory factor analysis indicated good model fit. Criterion validity against SF-36 showed correlations of 0.56 (physical), 0.54 (psychological), and 0.46 (social). Internal consistency was high (Cronbach's α: 0.79-0.98). Significant pre- to post-treatment score differences were found (all p < 0.001), with standardized response means of 0.24 (physical), 0.17 (psychological), and 0.07 (social). IRT analysis indicated all items had discrimination parameters between 1.11 and 1.41, with monotonically increasing location parameters. Average item information amount was approximately 0.33 (physical), 0.54 (psychological), and 0.44(social).</p><p><strong>Conclusions: </strong>QLICD-GM(V2.0) provides a psychometrically sound, clinically interpretable and responsive measure of generic QoL in chronic patients. It can be used alone or combined with disease-specific modules to monitor benefit and guide treatment and rehabilitation planning.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-06DOI: 10.1186/s12955-026-02479-y
Nguyen Thi Lien Ha, Nguyen Binh Hoa, Manisha Yapa, Nguyen Thu Anh, Qingbin Li, Vu Hai Dang, Greg J Fox, Vu Quoc Dat
{"title":"Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam.","authors":"Nguyen Thi Lien Ha, Nguyen Binh Hoa, Manisha Yapa, Nguyen Thu Anh, Qingbin Li, Vu Hai Dang, Greg J Fox, Vu Quoc Dat","doi":"10.1186/s12955-026-02479-y","DOIUrl":"https://doi.org/10.1186/s12955-026-02479-y","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146124793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-06DOI: 10.1186/s12955-026-02489-w
Xutong Zheng, Yuhong Zhang, Liuxuan Xie, Yingshuo Liu, Qiuying Yu, Han Zhang, Yao Li, Aiping Wang
Objectives: This systematic review investigates the barriers, enablers and mechanisms affecting ePROMs implementation in CKD (chronic kidney disease) management, with a focus on the perspectives of patients and healthcare providers.
Methods: A qualitative systematic review was conducted using the UK Medical Research Council's Process Evaluation Framework to analyze studies on ePROM implementation in CKD care. We systematically searched databases for peer-reviewed qualitative studies published from inception to October 2025. Thematic analysis, guided by the Process Evaluation Framework, was used to synthesize the findings. Studies from PubMed, Embase, Scopus, CINAHL, and APA PsycINFO were included.
Results: Results Eleven studies met the inclusion criteria. The synthesis identified distinct barriers and mechanisms of impact. Key barriers included structural and technical obstacles: digital literacy gaps, cognitive overload in vulnerable populations, misalignment with clinical IT systems, interface usability issues, and inconsistent implementation protocols. Regarding Enablers and Mechanisms, the review revealed a paradox. While ePROMs acted as enablers for personalized treatment and improved symptom awareness, their effectiveness was mediated by complex relational mechanisms. Both patients and clinicians expressed skepticism regarding utility in routine care. Furthermore, relational tensions arose when patient input was perceived as overlooked, highlighting that patient empowerment is conditional on the quality of the therapeutic alliance.
Conclusion: ePROMs have the potential to enhance CKD care by providing valuable insights into patient experiences. However, their adoption is hindered by digital literacy, technological issues, and inconsistent protocols. To optimize adoption, policymakers must prioritize IT integration and standardized protocols, while clinicians should actively incorporate results into consultations to validate patient input. Future research should focus on mixed-methods studies in diverse populations to ensure equitable and effective implementation.
{"title":"Implementing electronic Patient-Reported Outcome Measures in Chronic Kidney Disease: a qualitative systematic review of barriers, enablers, and mechanisms.","authors":"Xutong Zheng, Yuhong Zhang, Liuxuan Xie, Yingshuo Liu, Qiuying Yu, Han Zhang, Yao Li, Aiping Wang","doi":"10.1186/s12955-026-02489-w","DOIUrl":"https://doi.org/10.1186/s12955-026-02489-w","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review investigates the barriers, enablers and mechanisms affecting ePROMs implementation in CKD (chronic kidney disease) management, with a focus on the perspectives of patients and healthcare providers.</p><p><strong>Methods: </strong>A qualitative systematic review was conducted using the UK Medical Research Council's Process Evaluation Framework to analyze studies on ePROM implementation in CKD care. We systematically searched databases for peer-reviewed qualitative studies published from inception to October 2025. Thematic analysis, guided by the Process Evaluation Framework, was used to synthesize the findings. Studies from PubMed, Embase, Scopus, CINAHL, and APA PsycINFO were included.</p><p><strong>Results: </strong>Results Eleven studies met the inclusion criteria. The synthesis identified distinct barriers and mechanisms of impact. Key barriers included structural and technical obstacles: digital literacy gaps, cognitive overload in vulnerable populations, misalignment with clinical IT systems, interface usability issues, and inconsistent implementation protocols. Regarding Enablers and Mechanisms, the review revealed a paradox. While ePROMs acted as enablers for personalized treatment and improved symptom awareness, their effectiveness was mediated by complex relational mechanisms. Both patients and clinicians expressed skepticism regarding utility in routine care. Furthermore, relational tensions arose when patient input was perceived as overlooked, highlighting that patient empowerment is conditional on the quality of the therapeutic alliance.</p><p><strong>Conclusion: </strong>ePROMs have the potential to enhance CKD care by providing valuable insights into patient experiences. However, their adoption is hindered by digital literacy, technological issues, and inconsistent protocols. To optimize adoption, policymakers must prioritize IT integration and standardized protocols, while clinicians should actively incorporate results into consultations to validate patient input. Future research should focus on mixed-methods studies in diverse populations to ensure equitable and effective implementation.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Validation of the Japanese version of boredom proneness scale and derivation of its short version among older adults: a cross-sectional study.","authors":"Atsushi Takayama, Izumi Uehara, Takashi Yoshioka, Taro Takeshima, Kenji Omae, Sayaka Shimizu, Hiroaki Nakagawa, Akihiro Ozaka, Sugihiro Hamaguchi, Shunichi Fukuhara","doi":"10.1186/s12955-026-02490-3","DOIUrl":"https://doi.org/10.1186/s12955-026-02490-3","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-04DOI: 10.1186/s12955-026-02487-y
Stanley Carries, Juliet Nyasulu, Audrey Moyo, Eugene Lee Davids, Willem Odendaal, Darshini Govindasamy
{"title":"A synthesis of dimensions of wellbeing among adolescents and young people living with HIV from Sub-Saharan Africa for measurement in economic evaluation: a qualitative overview of reviews.","authors":"Stanley Carries, Juliet Nyasulu, Audrey Moyo, Eugene Lee Davids, Willem Odendaal, Darshini Govindasamy","doi":"10.1186/s12955-026-02487-y","DOIUrl":"https://doi.org/10.1186/s12955-026-02487-y","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Health-related quality of life and associated factors among patients living with epilepsy of Mekelle City Hospitals, Northern Ethiopia: a multicenter observational study.","authors":"Gebremicheal Gebreyohanns Kahsay, Kidu Gidey, Alemseged Beyene Berha","doi":"10.1186/s12955-026-02480-5","DOIUrl":"https://doi.org/10.1186/s12955-026-02480-5","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02DOI: 10.1186/s12955-026-02485-0
Yun Liu, Xinyu Du, Zheng Rong, Zhen Guo, Feng Chang, Yun Lu, Zhanjing Dai, Yuqiong Lu
<p><strong>Background: </strong>In cases where clinical efficacy and safety profiles are similar, patient preferences for the treatment process become a critical determinant of therapeutic adherence and health-related quality of life (HRQoL). However, current research on the utility of treatment process attributes (such as administration route, frequency, and time) show significant heterogeneity. Moreover, the results are often influenced by confounding factors, making it difficult to quantify their independent utility impact.</p><p><strong>Objectives: </strong>This study aims to deconstruct prevalent confounding biases through a systematic review and multivariable meta-regression. The goal is to isolate the independent effects of various treatment process attributes on health utility values, thereby providing more precise evidence for pharmacoeconomic evaluations.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this study systematically searched PubMed, Cochrane Library, Web of Science, and EBSCO databases for relevant English-language literature published up to December 2024. Original research reporting health utility values (on a 0-1 scale) associated with pharmaceutical treatment process attributes was included. Extracted disutility values, defined as Disutility=Utility - 1, were analyzed using random-effects models. Univariate, bivariate, and multivariable meta-regression models were constructed to control for key confounders, such as disease type and respondent population (patients vs. general public), and to investigate the independent effects of administration route, frequency, and duration on utility values.</p><p><strong>Results: </strong>Nineteen studies (providing 81 utility values) met inclusion criteria. In fully adjusted models, administration route emerged as a primary determinant of utility. Injection (versus oral) conferred a significant disutility (β = - 0.092; 95% CI - 0.127 to - 0.056; p < 0.001). Administration durations > 1 h also imposed significant disutility (β = - 0.172; 95% CI - 0.289 to - 0.055; p < 0.005). Disease severity was the strongest predictor overall: utilities for neoplasms were over 0.4 lower than for metabolic conditions (p < 0.001). Patients consistently reported higher utilities than the general public. An apparent "frequency paradox" (greater disutility for lower dosing frequency) emerged in unadjusted analysis, but this effect disappeared after adjusting for route, indicating it was a statistical artifact of confounding by route. No independent effect of dosing frequency remained in multivariable analysis.</p><p><strong>Conclusion: </strong>Injectable route and prolonged administration duration are significant, independent drivers of health disutility. The apparent negative effect of dosing frequency is a statistical artifact of confounding by the administration route, which carries the actual disutility. These findin
背景:在临床疗效和安全性相似的情况下,患者对治疗过程的偏好成为治疗依从性和健康相关生活质量(HRQoL)的关键决定因素。然而,目前对治疗过程属性(如给药途径、频率和时间)效用的研究显示出显著的异质性。此外,结果往往受到混杂因素的影响,使其难以量化其独立的效用影响。目的:本研究旨在通过系统回顾和多变量元回归分析来解构普遍存在的混淆偏差。目的是分离各种治疗过程属性对健康效用值的独立影响,从而为药物经济学评估提供更精确的证据。方法:本研究遵循PRISMA (Preferred Reporting Items for Systematic Reviews and meta - analysis)指南,系统检索PubMed、Cochrane Library、Web of Science和EBSCO数据库,检索截止2024年12月发表的相关英文文献。纳入了报告与药物处理过程属性相关的健康效用值(0-1分)的原始研究。提取的负效用值定义为负效用=效用- 1,使用随机效应模型进行分析。建立了单变量、双变量和多变量元回归模型来控制关键混杂因素,如疾病类型和应答人群(患者与公众),并调查给药途径、频率和持续时间对效用值的独立影响。结果:19项研究(提供81个实用价值)符合纳入标准。在完全调整后的模型中,给药途径成为效用的主要决定因素。注射(与口服相比)具有显著的负效用(β = - 0.092; 95% CI - 0.127至- 0.056;p 1 h也具有显著的负效用(β = - 0.172; 95% CI - 0.289至- 0.055);p结论:注射途径和延长给药时间是显著的、独立的健康负效用驱动因素。给药频率的明显负面影响是由给药途径混淆的统计伪影,它带来了实际的负效用。这些发现强调了治疗属性的相互联系,并强调了一种整体的、多变量的测量方法是必要的,以避免药物经济学评估中混淆偏倚的错误结论。
{"title":"Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis.","authors":"Yun Liu, Xinyu Du, Zheng Rong, Zhen Guo, Feng Chang, Yun Lu, Zhanjing Dai, Yuqiong Lu","doi":"10.1186/s12955-026-02485-0","DOIUrl":"https://doi.org/10.1186/s12955-026-02485-0","url":null,"abstract":"<p><strong>Background: </strong>In cases where clinical efficacy and safety profiles are similar, patient preferences for the treatment process become a critical determinant of therapeutic adherence and health-related quality of life (HRQoL). However, current research on the utility of treatment process attributes (such as administration route, frequency, and time) show significant heterogeneity. Moreover, the results are often influenced by confounding factors, making it difficult to quantify their independent utility impact.</p><p><strong>Objectives: </strong>This study aims to deconstruct prevalent confounding biases through a systematic review and multivariable meta-regression. The goal is to isolate the independent effects of various treatment process attributes on health utility values, thereby providing more precise evidence for pharmacoeconomic evaluations.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this study systematically searched PubMed, Cochrane Library, Web of Science, and EBSCO databases for relevant English-language literature published up to December 2024. Original research reporting health utility values (on a 0-1 scale) associated with pharmaceutical treatment process attributes was included. Extracted disutility values, defined as Disutility=Utility - 1, were analyzed using random-effects models. Univariate, bivariate, and multivariable meta-regression models were constructed to control for key confounders, such as disease type and respondent population (patients vs. general public), and to investigate the independent effects of administration route, frequency, and duration on utility values.</p><p><strong>Results: </strong>Nineteen studies (providing 81 utility values) met inclusion criteria. In fully adjusted models, administration route emerged as a primary determinant of utility. Injection (versus oral) conferred a significant disutility (β = - 0.092; 95% CI - 0.127 to - 0.056; p < 0.001). Administration durations > 1 h also imposed significant disutility (β = - 0.172; 95% CI - 0.289 to - 0.055; p < 0.005). Disease severity was the strongest predictor overall: utilities for neoplasms were over 0.4 lower than for metabolic conditions (p < 0.001). Patients consistently reported higher utilities than the general public. An apparent \"frequency paradox\" (greater disutility for lower dosing frequency) emerged in unadjusted analysis, but this effect disappeared after adjusting for route, indicating it was a statistical artifact of confounding by route. No independent effect of dosing frequency remained in multivariable analysis.</p><p><strong>Conclusion: </strong>Injectable route and prolonged administration duration are significant, independent drivers of health disutility. The apparent negative effect of dosing frequency is a statistical artifact of confounding by the administration route, which carries the actual disutility. These findin","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The association between disease status and health-related quality of life: evidence from a cross-sectional survey across mainland China.","authors":"Xinyi Li, Xuedi Ma, Changcheng Shi, Wangjun Qin, Yibo Wu, Lihong Liu","doi":"10.1186/s12955-026-02481-4","DOIUrl":"https://doi.org/10.1186/s12955-026-02481-4","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-31DOI: 10.1186/s12955-026-02486-z
Valeriia Sokolova, Jan Faller, Thao Thai, Lidia Engel
Background: Dementia does not only impact the quality of life of the affected individual but also their family and informal caregivers, often referred to as health spillover effects. Increasing attention is being given to the inclusion of informal caregiver spillover effects in economic evaluations, given their potential to directly influence funding recommendations.
Objective: The objective of this study was to estimate the relative health spillover effects of dementia caregiving on informal caregivers using the EQ Health and Wellbeing 9-items (EQ-HWB-9) questionnaire.
Methods: A cross-sectional survey was conducted involving informal caregivers of people with dementia residing in Australia. Informal caregivers completed the experimental version of EQ-HWB to rate their own health and wellbeing and proxy reported for the person with dementia using the EQ-HWB-9. To estimate the relative spillover, univariate and multiple linear regressions modeled caregiver's EQ-HWB-9 scores (derived from the EQ-HWB) as a function of the person with dementia health and wellbeing (based on the EQ-HWB-9), adjusting for demographic and caregiving characteristics.
Results: In total, 202 informal caregivers completed the survey. The average age of caregivers was 60.4 (SD = 13.7), with 63.2% being female. The univariate analysis revealed a positive relative spillover effect coefficient of 0.23 (p < 0.001, R-squared = 0.10), demonstrating a significant positive association between caregiver's and person's with dementia health and wellbeing using the EQ-HWB-9. This relationship remained significant (p < 0.001, adj R-squared = 0.26) when adjusting for caregiver's chronic conditions in the multiple linear regression model yielding a spillover coefficient of 0.22. Most impacted domains of caregiving included exhaustion, loneliness and lack of control over day-to-day life.
Conclusions: There is evidence of associative relative health spillovers associated with providing informal care for a person with dementia. It is essential to include health effects on informal caregivers into economic evaluations to account for the burden of dementia posed beyond the affected individual.
{"title":"Exploring relative health spillover effects within the context of dementia using the EQ-HWB-9.","authors":"Valeriia Sokolova, Jan Faller, Thao Thai, Lidia Engel","doi":"10.1186/s12955-026-02486-z","DOIUrl":"https://doi.org/10.1186/s12955-026-02486-z","url":null,"abstract":"<p><strong>Background: </strong>Dementia does not only impact the quality of life of the affected individual but also their family and informal caregivers, often referred to as health spillover effects. Increasing attention is being given to the inclusion of informal caregiver spillover effects in economic evaluations, given their potential to directly influence funding recommendations.</p><p><strong>Objective: </strong>The objective of this study was to estimate the relative health spillover effects of dementia caregiving on informal caregivers using the EQ Health and Wellbeing 9-items (EQ-HWB-9) questionnaire.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted involving informal caregivers of people with dementia residing in Australia. Informal caregivers completed the experimental version of EQ-HWB to rate their own health and wellbeing and proxy reported for the person with dementia using the EQ-HWB-9. To estimate the relative spillover, univariate and multiple linear regressions modeled caregiver's EQ-HWB-9 scores (derived from the EQ-HWB) as a function of the person with dementia health and wellbeing (based on the EQ-HWB-9), adjusting for demographic and caregiving characteristics.</p><p><strong>Results: </strong>In total, 202 informal caregivers completed the survey. The average age of caregivers was 60.4 (SD = 13.7), with 63.2% being female. The univariate analysis revealed a positive relative spillover effect coefficient of 0.23 (p < 0.001, R-squared = 0.10), demonstrating a significant positive association between caregiver's and person's with dementia health and wellbeing using the EQ-HWB-9. This relationship remained significant (p < 0.001, adj R-squared = 0.26) when adjusting for caregiver's chronic conditions in the multiple linear regression model yielding a spillover coefficient of 0.22. Most impacted domains of caregiving included exhaustion, loneliness and lack of control over day-to-day life.</p><p><strong>Conclusions: </strong>There is evidence of associative relative health spillovers associated with providing informal care for a person with dementia. It is essential to include health effects on informal caregivers into economic evaluations to account for the burden of dementia posed beyond the affected individual.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-30DOI: 10.1186/s12955-026-02483-2
Shujie Dong, Yajing Li, Ziqiong Liao, Qi Lin, Hei Hang Edmund Yiu, Wai-Kit Ming, Lei Li, Rongsheng Zhao
{"title":"A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy.","authors":"Shujie Dong, Yajing Li, Ziqiong Liao, Qi Lin, Hei Hang Edmund Yiu, Wai-Kit Ming, Lei Li, Rongsheng Zhao","doi":"10.1186/s12955-026-02483-2","DOIUrl":"https://doi.org/10.1186/s12955-026-02483-2","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}